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Abstract	16	 The	heteroleptic	complexes	[Ru(1)(4)][PF6]2,	[Ru(2)(4)][PF6]2,	17	 [Ru(Phtpy)(4)][PF6]2	and	[Ru(pytpy)(4)][PF6]2	(Phtpy	=	4'-phenyl-18	 2,2':6',2''-terpyridine,	pytpy	=	4'-(4-pyridyl)-2,2':6',2''-terpyridine,	1	and	2	=	19	 4-methyl	ester-substituted	derivatives	of	Phtpy	and	pytpy,	4	=	ethyl	20	 2,2':6',2''-terpyridine-4'-phosphonate)	have	been	prepared.	The	single	21	 crystal	structure	of	ligand	1	(1	=	methyl	4-carboxy-4'-phenyl-2,2':6',2''-22	 terpyridine)	is	reported.	The	introduction	of	the	4-methyl	ester	group	23	 causes	a	small	red	shift	in	the	MLCT	band	of	the	ruthenium(II)	complexes,	24	 and	small	shift	to	more	positive	potential	for	the	Ru2+/Ru3+	couple.	The	new	25	
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complexes	should	serve	as	a	useful	starting	point	for	development	of	26	 ruthenium(II)	dyes	suited	for	sensitization	of	p-type	semiconductors.	27	 	28	 	29	
Introduction	30	 The	{Ru(tpy)2}	chromophore	(tpy	=	2,2':6',2''-terpyridine)	is	one	of	the	most	31	 extensively	studied	domains1	within	metal	oligopyridine	coordination	32	 chemistry.	Tuning	the	photophysical	and	electrochemical	properties	of	33	 {Ru(tpy)2}-containing	complexes	is	readily	achieved	through	34	 functionalization	of	the	ligand.	In	particular,	the	Kröhnke	methodology2	is	a	35	 facile	means	of	introducing	a	wide	variety	of	substituents	into	the	4'-36	 position	of	tpy.	Although	at	room	temperature	in	solution,	[Ru(tpy)2]2+	is	37	 essentially	non-emissive,3	judicious	choice	of	electron-donating	or	accepting	38	 substituents	can	lead	to	significant	enhancement	of	emission	properties.4		39	 	 Among	the	many	areas	in	which	ruthenium(II)	complexes	containing	40	 tpy-derived	ligands	have	found	a	practical	niche	is	that	of	the	Grätzel	solar	41	 cell.5	Our	own	interests	in	the	development	of	sensitizers	for	the	42	 photoanode	in	dye-sensitized	solar	cells	(DSCs)	have	moved	in	the	direction	43	 of	earth-abundant	metals,	in	particular	copper.6	Although	photon-to-power	44	 conversion	efficiencies	reaching	3.77%7	have	been	achieved	with	a	45	 copper(I)	sensitizer	anchored	to	the	n-type	semiconductor	(TiO2)	46	 comprising	the	photoanode,	this	is	significantly	lower	than	those	attained	by	47	 state-of-the-art	ruthenium(II)	dyes	(>10%).8	One	strategy	for	improving	48	 performance	is	to	harvest	photons	at	both	electrodes,	but	this	requires	49	 different	dyes	suited	for	interaction	with	either	the	photoanode	(n-type	50	
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semiconductor)	or	photocathode	(p-type)	in	a	so-called	tandem	cell.9		In	a	51	 tandem	DSC,	the	photocathode	functions	in	an	inverse	mode	with	respect	to	52	 the	photoanode,	with	excitation	of	the	dye	being	followed	by	rapid	hole	53	 injection	into	the	p-type	semiconductor	(e.g.	NiO).	Organic	donor–acceptor	54	 molecules	are	popular	choices	for	photocathode	sensitizers.10	Excitation	of	55	 the	sensitizer	leaves	a	hole	in	the	original	HOMO	of	the	dye	into	which	an	56	 electron	is	transferred	from	the	valence	band	of	the	p-type	semiconductor.	57	 Thus,	the	HOMO/LUMO	requirements	of	a	p-type	sensitizer	are	the	reverse	58	 of	those	of	an	n-type	dye.	It	has	been	demonstrated	that	[Ru(bpy)2(N^N)]2+	59	 (bpy	=	2,2'-bipyridine,	N^N	=	bipyridine-based	anchoring	ligand)	complexes	60	 sensitize	NiO	photocathodes	and	both	CO2H	and	PO(OH)2	anchors	adsorb	61	 onto	NiO.11	Ruthenium(II)	complexes	containing	cyclometalated	ligands,	62	 and	related	to	the	archetypal	[Ru(bpy)2(ppy)]+	12,13	(Hppy	=	2-63	 phenylpyridine)	are	also	promising	candidates	for	NiO	sensitization.14,15		64	 	 Low	level	MO	calculations	indicate	that	the	HOMO	of	[Ru(tpy)(4'-65	 (HO)2OPtpy)]2+	type	complexes	(4'-(HO)2OPtpy	=	2,2':6',2''-terpyridine-4'-66	 phosphonic	acid)	may	be	localized	on	the	phosphonic	acid	anchoring	unit.	67	 We	have	therefore	undertaken	a	preliminary	investigation	of	several	68	 complexes	of	this	type	with	the	aim	of	provding	a	starting	point	for	the	69	 development	of	dyes	for	p-type	semiconductors.	The	ancillary	ligands	1	and	70	
2	(Scheme	1)	contain	an	ester	functionality	which	provides	a	site	for	71	 variable	functionalization,	for	example,	through	transesterification.	72	 	 	73	 	74	
Experimental	75	
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General:	1H	and	13C	NMR	spectra	were	recorded	at	295	K	on	Bruker	Avance	76	 III-400	or	III-500	NMR	spectrometers	(chemical	shifts	with	respect	to	77	 residual	solvent	peaks	and	∂(TMS)	=	0	ppm).	Solution	electronic	absorption	78	 and	emission	spectra	were	measured,	respectively,	using	an	Agilent	8453	79	 spectrophotometer	and	Shimadzu	5301PC	spectrofluorophotometer.	80	 Solution	quantum	yields	were	measured	using	a	Hamamatsu	absolute	PL	81	 quantum	yield	spectrometer	C11347	Quantaurus_QY.	A	Shimadzu	8400S	82	 spectrometer	was	used	to	record	FT-IR	spectra	(all	solid	samples	using	a	83	 Golden	Gate	accessory).	Electrospray	ionization	(ESI)	mass	spectra	and	84	 high-resolution	ESI	mass	spectra	were	recorded	on	Bruker	esquire	3000plus	85	 and	Bruker	maXis	4G	mass	spectrometers.	Electrochemical	measurements	86	 were	carried	out	using	cyclic	voltammetry	and	were	recorded	using	a	CH	87	 Instruments	900B	potentiostat		with	glassy	carbon	working	and	platinum	88	 auxiliary	electrodes;	a	silver	wire	was	used	as	a	pseudo-reference	electrode.	89	 The	solvent	was	HPLC	grade	MeCN	and	0.05	M	[nBu4N][PF6]	was	used	as	90	 supporting	electrolyte.	All	solutions	were	degassed	with	argon,	and	Cp2Fe	91	 was	used	as	internal	reference.	A	Biotage	Initiator	8	reactor	was	used	for	92	 reactions	under	microwave	conditions.	Fluka	silica	60	was	used	for	column	93	 chromatography.	94	 	 The	compounds	(E)-1-(pyridin-2-yl)-3-(pyridin-4-yl)prop-2-en-1-95	 one,16		(E)-3-phenyl-1-(pyridin-2-yl)prop-2-en-1-one,17	1-(2-(4-96	 (methoxycarbonyl)pyridin-2-yl)-2-oxoethyl)pyridin-1-ium	iodide,16	Phtpy17	97	 pytpy18	and	4'-F3CSO3-2,2':6',2''-terpyridine19	were	prepared	according	to	98	 published	methods	(Phtpy	=	4'-phenyl-2,2':6',2''-terpyridine,	pytpy	=	4'-(4-99	 pyridyl)-2,2':6',2''-terpyridine).		RuCl3⋅3H2O was purchased from OXKEM.	100	
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Compound	1	102	 Ammonium	acetate	(9.60	g,	124.68	mmol)	was	dissolved	in	MeOH	(110	mL).	103	 (E)-3-Phenyl-1-(pyridin-2-yl)prop-2-en-1-one	(1.00	g,	4.76	mmol)	and	1-(2-104	 (4-(methoxycarbonyl)pyridin-2-yl)-2-oxoethyl)pyridin-1-ium	iodide	(2.21	105	 g,	5.71	mmol)	were	added	and	the	brown	solution	was	heated	at	reflux	for	106	 16	h,	during	which	time	a	brown	precipitate	formed.	The	reaction	mixture	107	 was	then	cooled	to	room	temperature	and	left	to	stand	overnight	in	a	108	 freezer.	The	brown	precipitate	was	collected	on	a	glass	frit,	washed	with	109	 cold	MeOH	and	dried	in	air.	Compound	1	was	isolated	as	a	pale	brown	110	 powder	(0.56	g,	1.53	mmol,	33%).	M.Pt.	197-198	°C.	1H	NMR	(500	MHz,	111	 CDCl3)	∂/ppm	9.16	(dd,	J	=	1.7,	0.9	Hz,	1H,	HD3),	8.86	(dd,	J	=	5.0,	0.9	Hz,	1H,	112	 HD6),	8.78	(d,	J	=	1.7	Hz,	1H,	HB3),	8.75	(d,	J	=	1.7	Hz,	1H,	HB5),	8.74	(ddd,	J	=	113	 4.7,	1.9,	1.0	Hz,	1H,	HA6),	8.72	(dt,	J	=	7.9,	1.1	Hz,	1H,	HA3),	7.90	(m,	4H,	114	 HA4+C2+D5),	7.52	(m,	2H,	HC3),	7.47	(m,	1H,	HC4),	7.37	(ddd,	J	=	7.5,	4.8,	1.2	Hz,	115	 1H,	HA5),	4.04	(s,	3H,	HOMe).	13C	{1H}	NMR	(126	MHz,	CDCl3)	∂	/	ppm	166.1	116	 (CC=O),	157.6	(CD2),	156.2	(CA2),	156.1	(CB2),	155.3	(CB6),	150.6	(CB4),	150.0	117	 (CD6),	149.2	(CA6),	138.5	(CC1),	138.4	(CD4),	137.2	(CA4),	129.3	(CC4),	129.1	118	 (CC3),	127.5	(CC2),	124.1	(CA5),	122.9	(CD5),	121.7	(CA3),	120.8	(CD3),	119.5	119	 (CB5),	119.3	(CB3),	52.9	(COMe).	ESI-MS	(MeOH/CHCl3):	m/z	390.0	[M+Na]+	120	 (calc.	390.1),	368.0	[M+H]+	(base	peak,	calc.	368.1).	IR	(solid,	ν/cm–1)	3051	121	 (w),	2969	(w),	1723	(s),	1583	(m),	1548	(m),	1467	(w),	1432	(m),	1378	(s),	122	 1268	(s),	1218	(s),	1132	(w),	1099	(w),	989	(m),	887	(w),	800	(m),	775	(m),	123	 764	(s),	754	(s),	731	(s),	707	(s),	694	(s),	681	(s),	662	(s),	620	(s),	517	(s).	124	 UV/VIS	λ/nm	(CH3CN,	4.44	×	10–5	mol	dm–3)	(ε	/	dm3	mol–1	cm–1)	253	125	
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(35000),	276	sh	(27000),	310	sh	(13000).	Found	C,	74.41;	H,	4.67;	N,	11.22;	126	 C23H17N3O2⋅0.25H2O	requires	C,	74.28;	H,	4.74;	N,	11.30%.	127	 	128	 	129	
	130	
Compound	2	131	
Ammonium	acetate	(13	g,	160	mmol)	was	dissolved	in	MeOH	(150	mL).	(E)-132	 1-(Pyridin-2-yl)-3-(pyridin-4-yl)prop-2-en-1-one	(0.92	g,	4.38	mmol)	and	1-133	 (2-(4-(methoxycarbonyl)pyridin-2-yl)-2-oxoethyl)pyridin-1-ium	iodide	134	 (2.01	g,	5.25	mmol)	were	added	and	the	brown	suspension	was	heated	at	135	 reflux	for	7	h;	the	solids	slowly	dissolved.	The	white	precipitate	which	136	 formed	was	collected	on	a	glass	frit,	washed	with	cold	MeOH	and	Et2O,	and	137	 dried	in	air.	Compound	2	was	isolated	as	a	white	powder	(1.43	g,	3.88	mmol,	138	 89%).	M.Pt.	216-217	°C.	1H	NMR	(500	MHz,	CDCl3)	∂/ppm	9.15	(dd,	J	=	1.6,	139	 0.9	Hz,	1H,	HD3),	8.86	(dd,	J	=	5.0,	0.9	Hz,	1H,	HD6),	8.78	(d,	J	=	1.7	Hz,	1H,	140	 HB3),	8.76	(m,	3H,	HC2+B5),	8.72	(m,	2H,	HA6+A3),	7.92	(m,	2H,	HA4+D5),	7.80	(dd,	141	
J	=	4.5,	1.7	Hz,	2H,	HC3),	7.39	(ddd,	J	=	7.5,	4.8,	1.3	Hz,	1H,	HA5),	4.04	(s,	3H,	142	 HOMe).	13C	{1H}	NMR	(126	MHz,	CDCl3)	∂/ppm	165.9	(CC=O),	156.9	(CD2),	143	 156.7	(CB2),	155.6	(CB6),	155.5	(CA2),	150.6	(CC2),	150.0	(CD6),	149.3	(CA6),	144	 147.6	(CB4),	145.9	(CC4),	138.5	(CD4),	137.2	(CA4),	124.3	(CA5),	123.2	(CD5),	145	 121.7	(CC3),	121.6	(CA3),	120.7	(CD3),	119.1	(CB3),	118.9	(CB5),	53.0	(COMe).	ESI	146	 MS	(MeOH/CHCl3):	m/z	391.1	[M+Na]+	(base	peak,	calc.	391.1),		369.2	147	 [M+H]+	(calc.	369.1).	IR	(solid,	ν/cm–1)	3020	(w),	2961	(w),	1731	(s),	1583	148	 (m),	1559	(m),	1538	(m),	1533	(m),	1475	(m),	1436	(m),	1378	(m),	1309	149	
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(w),	1292	(w),	1270	(m),	1263	(w),	1218	(m),	1211	(m),	1130	(w),	973	(w),	150	 895	(w),	821	(m),	795	(s),	770	(s),	736	(w),	682	(m),	669	(m),	660	(m),	618	151	 (m),	533	(m).	UV/VIS	λ/nm	(ε		/	dm3	mol–1	cm–1)	(CH3CN,	4.22	×	10–5	mol	152	 dm–3)	242	(33000),	281	(16000),	316	sh	(10000).	Found	C,	70.96;	H,	4.44;	N,	153	 15.19;	C22H16N4O2⋅0.25H2O	requires	C,	70.86;	H,	4.46;	N,	15.02%.	154	 	155	
Compound	3	156	 4'-F3CSO3-2,2':6',2''-Terpyridine	(0.80	g,	2.10	mmol)	and	[Pd(PPh3)4]	(0.24	157	 g,	0.21	mmol)	were	suspended	in	MeCN	(17	mL)	in	a	microwave	vial	(20	158	 mL),	and	then	NEt3	(0.38	g,	3.78	mmol)	and	diethyl	phosphite	(0.49	g,	3.57	159	 mmol)	were	added.	The	brown	suspension	was	heated	in	a	microwave	160	 reactor	(140	°C,	30	min)	and	then	allowed	to	cool	to	room	temperature.	The	161	 reaction	mixture	was	diluted	with	toluene	and	washed	with	aqueous	NH4OH	162	 (32%)	and	H2O.	The	organic	layer	was	dried	over	MgSO4,	filtered	and	the	163	 solvent	removed	in	vacuo.	The	crude	brown	solid	was	purified	by	flash	164	 column	chromatography	(SiO2),	first	eluting	with	CH2Cl2	to	remove	Ph3PO	165	 and	then	with	CH2Cl2/MeOH	(98	:	2).	Compound	3	was	isolated	as	a	pale	166	 brown	solid	(0.65	g,	1.76	mmol,	84%).	The	NMR	spectroscopic	data	matched	167	 those	published.20	168	 	169	
[Ru(3)Cl3]		170	 Compound	3	(0.60	g,	1.63	mmol)	and	RuCl3⋅3H2O	(0.43	g,	1.63	mmol)	were	171	 suspended	in	EtOH	(200	mL)	and	the	reaction	mixture	was	heated	at	reflux	172	 for	3.5	h.	The	brown	solid	which	formed	was	separated	by	filtration,	washed	173	 with	cold	EtOH	and	Et2O	and	dried	in	air	yielding	a	red-brown	powder	(0.83	174	
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g,	1.44	mmol,	88%).	The	product	was	used	for	the	next	step	without	further	175	 purification	and	characterization.	176	 	177	
[Ru(Phtpy)(4)][PF6]2			178	 Phtpy	(64	mg,	0.21	mmol)	and	[Ru(3)Cl3]	(119	mg,	0.21	mmol)	were	179	 suspended	in	dry	EtOH	(3.5	mL)	in	a	microwave	reactor	vial.	N-180	 Ethylmorpholine	(3	drops)	was	added	and	the	reaction	mixture	was	heated	181	 in	a	microwave	reactor	at	140	°C	for	15	min.	The	dark	red	solution	was	182	 poured	into	aqueous	NH4PF6	(250	mL)	yielding	a	red	precipitate	which	was	183	 collected	on	Celite	and	washed	with	cold	water	(250	mL)	and	Et2O	(20	mL).	184	 The	residue	was	redissolved	in	CH3CN	and	then	solvent	removed	in	vacuo	to	185	 give	a	dark	red	solid.	This	was	purified	by	column	chromatography	(SiO2,	186	 eluted	with	CH3CN/saturated	aqueous	KNO3/H2O	7	:	1	:	0.5	by	vol.).	The	first	187	 red	band	was	collected,	aqueous	NH4PF6	added	and	solvent	evaporated	until	188	 a	red	precipitate	formed.	This	was	collected	on	Celite	and	washed	189	 thoroughly	with	cold	H2O	(250	mL),	cold	EtOH	(15	mL)	and	Et2O	(15	mL).	190	 The	residue	was	redissolved	in	CH3CN	and	solvent	removed	in	vacuo.	191	 [Ru(Phtpy)(4)][PF6]2	was	isolated	as	a	red	powder	(200	mg,	0.192	mmol,	192	 93%).	1H	NMR	(400	MHz,	CD3CN)	∂/ppm	9.06	(d,	JPH	=	11	Hz,	2H,	HF3),		8.99	193	 (s,	2H,	HB3),	8.68	(m,	4H,	HA3+E3),	8.20	(m,	2H,	HC2),	7.90	(m,	4H,	HA4+E4),	7.76	194	 (m,	2H,	HC3),	7.68	(m,	1H,	HC4),	7.39	(m,	4H,	HA6+E6),	7.15	(m,	4H,	HA5+E5),	4.05	195	 (m,	2H,	HCH2(Et)),	1.31	(t,	J	=	7.0	Hz,	3H,	HCH3(Et)).	13C	{1H}	NMR	(126	MHz,	196	 CD3CN)	∂/ppm	159.3	(CE2),	158.8	(CA2),	156.2	(CB2),	155.7	(d,	JPC	=	12	Hz,	197	 CF2),	153.7	(CA6/E6),	153.3	(CA6/E6),	149.2	(CB4),	139.0	(CA4+E4),	137.9	(CC1),	198	 131.3	(CC4),	130.6	(CC3),	128.7	(CC2),	128.5	(CA5/E5),	128.2	(CA5/E5),	126.4	(d,	199	
	 9	
JPC	=	20	Hz,	CF3),	125.6	(CA3/E3),	125.4	(CA3/E3),	122.5	(CB3),	61.8	(CCH2(Et)),	200	 17.5	(CCH3(Et))	(CF4	not	resolved).	IR	(solid,	ν/cm–1)	3315	(br	m),	1662	(w),	201	 1605	(w),	1542	(w),	1473	(w),	1412	(m),	1392	(m),	1345	(m),	1289	(w),	202	 1209	(m),	1162	(w),	1140	(m),	1078	(m),	1034	(m),	962	(w),	898	(w),	826	203	 (s),	791	(s),	764	(s),	733	(m),	689	(s),	664	(m),	603	(m).	ESI-MS	(MeCN):	m/z	204	 751.4	[M	–	H	–	2PF6]+	(100%,	calc.	751.1).	HR	ESI-MS	m/z:	376.0621	[M	–	205	 2PF6]2+	(base	peak,	calc.	376.0619),	751.1172	[M	–	H	–	2PF6]+	(calc.	206	 751.1165).	UV/VIS	λ	/	nm	(MeCN,	2.88	×	10–5	mol	dm–3)	(ε	/	dm3	mol–1	cm–207	
1)	274	(59000),	280	sh	(54500),	310	(63000),	330	sh	(34000),	485	(23000).	208	 Emission	(MeCN,	3	×	10–5	mol	dm–3,	λex	=	485	nm):	λem	=	647	nm.	209	 Satisfactory	elemental	analysis	could	not	be	obtained	(see	text).	210	 	211	
[Ru(pytpy)(4)][PF6]2			212	 The	method	was	as	for	[Ru(Phtpy)(4)][PF6]2	starting	with	pytpy	(160	mg,	213	 0.52	mmol)	and	[Ru(3)Cl3]	(300	mg,	0.52	mmol).	[Ru(pytpy)(4)][PF6]2	was	214	 isolated	as	a	red	powder	(130	mg,	0.125	mmol,	24%).	1H	NMR	(500	MHz,	215	 CD3CN)	∂/ppm	9.05	(d,	JPH	=	11	Hz,	2H,	HF3),	9.03	(s,	1H,	HB3),	8.95	(m,	2H,	216	 HC2),	8.64	(d,	J	=	7.9	Hz,	2H,	HA3/E3),	8.61	(d,	J	=	8.1	Hz,	2H,	HA3/E3),	8.12	(m,	217	 2H,	HC3),	7.94	(m,	2H,	HA4/E4),	7.88	(m,	2H,	HA4/E4),	7.42	(d,	J	=	6.7	Hz,	2H,	218	 HA6/E6),	7.35	(d,	J	=	6.7	Hz,	2H,	HE6),	7.18	(m,	2H,	HA5/E5),	7.15	(m,	2H,	HA5/E5),	219	 4.05	(m,	2H,	HCH2(Et)),	1.32	(t,	J	=	6.8	Hz,	3H,	HCH3(Et)).	13C	{1H}	NMR	(126	220	 MHz,	CD3CN)	∂/ppm	158.7	(CE2),	158.5	(CA2),	158.0	(CF2),	157.0	(CB2),	153.8	221	 (CA6/E6),	153.7	(CA6/E6),	151.5	(CC2),	145.3	(CB4+C4),	139.3	(CA4+E4),	128.8	222	 (CA5/E5),	128.6	(CA5/E5),	126.2	(d,	JPC	≈	20	Hz,	CF3),	126.1	(CA3/E3),	126.0	223	 (CA3/E3),	123.2	(CB3),	123.1	(CC3),	63.2	(CCH2(Et)),	17.2	(CCH3(Et))	(CF4	not	224	
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resolved).	IR	(solid,	ν/cm–1)	3350	(br	s),	1660	(w),	1599	(s),	1532	(w),	1475	225	 (m),	1394	(m),	1352	(w),	1291	(w),	1202	(s),	1166	(w),	1075	(m),	1069	(m),	226	 1038	(m),	1028	(s),	942	(m),	844	(s),	826	(s),	818	(s),	784	(m),	776	(m),	745	227	 (m).	ESI-MS	(CH3CN):	m/z	376.5	[M	–	2PF6]2+	(calc.	376.6).	HR	ESI-MS	m/z:	228	 376.5600	[M	–	2PF6]2+	(base	peak,	calc.	376.5595),	752.1135	[M	–	H	–	2PF6]+	229	 (calc.	752.1117).	UV/VIS	λ	/	nm	(CH3CN,	1	×	10–5	mol	dm–3)	(ε	/	dm3	mol–1	230	 cm–1)	273	(54700),	282	sh	(42000),	311	(50300),	331	sh	(33000),	486	231	 (21000).	Emission	(CH3CN,	3.84	×	10–5	mol	dm–3,	λex	=	486	nm):	λem	=	704	232	 nm.	Found:	C,	42.94;	H,	3.76;	N,	10.33;	C37H30F12N7O3P3Ru⋅H2O⋅1.5CH3CN	233	 (1122.60)	requires	C,	42.81;	H,	3.28;	N,	10.16%.	234	
	235	
[Ru(1)(4)][PF6]2		 		236	 The	method	was	as	for	[Ru(Phtpy)(4)][PF6]2	starting	with	1	(71	mg,	0.19	237	 mmol)	and	[Ru(3)Cl3]		(112	mg,	0.19	mmol).	[Ru(1)(4)][PF6]2	was	isolated	238	 as	a	red	powder	(177	mg,	0.161	mmol,	83%).	1H	NMR	(400	MHz,	CD3CN)	239	 ∂/ppm	9.15	(d,	J	=	1.4	Hz,	1H,	HB3/B5),	9.12	(d,	JPH	=	10.	Hz,	2H,	HF3),	9.08	(d,	J	240	 =	1.2	Hz,	1H,	HD3),	9.05	(d,	J	=	1.4	Hz,	1H,	HB3/B5),	8.72	(d,	J	=	8.2	Hz,	2H,	HE3),	241	 8.66	(d,	J	=	7.9	Hz,	1H,	HA3),	8.24	(m,	2H,	HC2),	7.94	(td,	J	=	7.9,	1.5	Hz,	1H,	242	 HA4),	7.89	(td,	J	=	7.9,	1.5	Hz,	2H,	HE4),	7.77	(m,	2H,	HC3),	7.69	(m,	1H,	HC4),	243	 7.63	(d,	J	=	5.8	Hz,	1H,	HD6),	7.56	(dd,	J	=	5.8,	1.8	Hz,	1H,	HD5),	7.44	(d,	J	=	5.5	244	 Hz,	1H,	HA6),	7.39	(dd,	J	=	5.6,	1.4	Hz,	2H,	HE6),	7.18	(m,	1H,	HA5),	7.13	(ddd,	J	245	 =	7.7,	5.6,	1.3	Hz,	2H,	HE5),	4.07	(m,	2H,	HCH2(Et)),	3.90	(s,	3H,	HOMe),	1.29	(t,	J	=	246	 7.0	Hz,	3H,	HCH3(Et)).	13C	{1H}	NMR	(126	MHz,	CD3CN)	∂/ppm	165.0	(CC=O),	247	 160.6	(CD2),	159.5	(CE2),	159.0	(CA2),	156.4	(CB2),	156.0	(CB6),	154.7	(CD6),	248	 155.6	(d,	JPC	=	14	Hz,	CF2),	153.7	(CA6),	153.3	(CE6),	149.4	(CB4),	139.4	(CD4),	249	
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139.2	(CA4+E4),	137.6	(CC1),	131.4	(CC4),	130.6	(CC3),	129.0	(CC2),	128.6	250	 (CA5+E5),	128.2	(CD5),	127.6	(d,	JPC	=	10	Hz,	CF3),	126.8	(CE3),	126.5	(CA3),	251	 125.1	(CD3),	124.0	(CB3/B5),	123.7	(CB3/B5),	62.1	(CCH2(Et)),	54.3	(COMe),	17.5	252	 (CCH3(Et))	(CF4	not	resolved).	IR	(solid,	ν/cm–1)	3347	(br	m),	1722	(w),	1605	253	 (w),	1363	(m),	1268	(w),	1165	(w),	1137	(w),	1075	(w),	1032	(w),	945	(w),	254	 825	(s),	787	(m),	767	(m),	700	(w),	607	(w).	ESI-MS	(CH3CN):	m/z	809.5	[M–255	 H–2PF6]+	(base	peak,	calc.	809.1).	HR	ESI-MS	m/z:	405.0654	[M	–	2PF6]2+	256	 (base	peak,	calc.	405.0647),	809.1233	[M	–	H	–	2PF6]+	(calc.	809.1220).	257	 UV/VIS	λ	/	nm	(CH3CN,	3.6	×	10-5	mol	dm-3)	(ε	/	dm3	mol–1	cm–1)	274	258	 (56000),	285	(51500),	309	(57000),	330	sh	(41500),	491	(20000).	259	 Satisfactory	elemental	analysis	was	not	obtained	(see	text).	260	
	261	
[Ru(2)(4)][PF6]2		 		262	 The	method	was	as	for	[Ru(Phtpy)(4)][PF6]2	starting	with	2	(50	mg,	0.14	263	 mmol)	and	[Ru(3)Cl3]	(78	mg,	0.14	mmol).	[Ru(2)(4)][PF6]2	was	isolated	as	264	 a	red	powder	(35	mg,	0.032	mmol,	23%).	1H	NMR	(500	MHz,	CD3CN)	∂/ppm	265	 9.23	(d,	JPH	=	11.5	Hz,	2H,	HF3)	overlapping	with	9.14	(d,	J	=	1.5	Hz,	1H,	266	 HB3/B5),	9.12	(d,	J	=	1.3	Hz,	1H,	HB3/B5),	9.09	(d,	J	=	1.4	Hz,	1H,	HD3),	8.98	(m,	267	 2H,	HC2),	8.77	(m,	3H,	HA3+E3),	8.19	(m,	2H,	HC3),	7.98	(td,	J	=	8.1,	1.4	Hz,	1H,	268	 HA4),	7.92	(td,	J	=	7.9,	1.5	Hz,	2H,	HE4),	7.61	(m,	2H,	HD5+D6),	7.46	(d,	J	=	5.6	Hz,	269	 1H,	HA6),	7.38	(dd,	J	=	5.7,	1.3	Hz,	2H,	HE6),	7.21	(m,	1H,	HA5),	7.16	(ddd,	J	=	270	 7.2,	5.6,	1.2	Hz,	2H,	HE5),	4.27	(m,	2H,	HCH2(Et)),	3.91	(s,	3H,	HOMe),	1.41	(t,	J	=	271	 6.9	Hz,	3H,	HCH3(Et)).	13C	{1H}	NMR	(126	MHz,	CD3CN)	∂/ppm	164.3	(CC=O),	272	 160.1	(CD2),	159.5	(CF2),	159.3	(CE2),	158.8	(CA2),	157.1	(CB2),	156.5	(CB6),	273	 154.8	(CD6),	153.7	(CA6),	153.4	(CE6),	151.7	(CC2),	146.4	(CB4),	145.2	(CC4),	274	
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139.4	(CA4),	139.3	(CE4),	128.6	(CA5),	128.5	(CE5),	127.3	(CD5),	126.4	(d,	JPC	≈	275	 10	Hz,	CF3),	126.0	(CE3),	125.7	(CA3),	124.4	(CB3/B5),	123.3	(CB3/B5),	123.0	276	 (CD3),	123.1	(CC3),	62.6	(CCH2(Et)),	53.8	(COMe),	16.9	(CCH3(Et))	(CF4	and	CD4	not	277	 resolved).	IR	(solid,	ν/cm–1)	3211	(br	s),	1729	(m),	1635	(w),	1600	(w),	278	 1475	(w),	1409	(m),	1344	(w),	1313	(m),	1268	(m),	1235	(m),	1165	(m),	279	 1138	(m),	1076	(m),	1030	(m),	950	(m),	826	(s),	786	(s),	753	(m),	688	(m),	280	 652	(m),	605	(m).	ESI-MS	(MeCN):	m/z	405.6	[M	–	2PF6]2+	(calc.	405.6).	HR	281	 ESI-MS	m/z:	405.5628	[M	–	2PF6]2+	(base	peak,	calc.	405.5623),	810.1187	[M	282	 –	H	–	2PF6]+	(calc.	810.1173).	UV/VIS	λ	/	nm	(CH3CN,	3.63	×	10–5	mol	dm–3)	283	 (ε	/	dm3	mol–1	cm–1)	274	(51000),	284	sh	(43500),	308	(45000),	330	sh	284	 (37000),	491	(18500).	Satisfactory	elemental	analysis	could	not	be	obtained	285	 (see	text).	286	 		287	
Crystal	structure	determination	of	1		288	 Data	were	collected	on	a	Bruker-Nonius	Kappa	APEX	diffractometer;	data	289	 reduction,	solution	and	refinement	used	APEX221	and	SHELX13.22	290	 Absorption	correction	was	made	using	the	program	'sadabs',	as	part	of	the	291	 'scale'	package	in	AEPX2	software.21	The	ORTEP	plot	was	produced	with	292	 Mercury	v.	3.023,24	which	was	also	used	for	structure		analysis.	C23H17N3O2,	M	293	 =	367.40,	colorless	plate,	crystal	dimensions	0.25	×	0.13	×	0.03	mm,	294	 monoclinic,	space	group	P21/c,	a	=	9.9644(9),	b	=	9.0359(8),	c	=	295	 20.0424(17)	Å,	β =	96.975(6)o,	U	=	1791.2(3)	Å3,	Z	=	4,	Dc	=	1.362	Mg	m–3,	296	
µ(Cu-Kα)	=	8.224		mm−1,	T	=	123	K.	Total	18887	reflections,	3181	unique,	297	
Rint	=	0.0428.	Refinement	of	2763	reflections	(254	parameters)	with	I	298	 >2σ	(I)	converged	at	final	R1	=	0.0378	(R1	all	data	=	0.0439),	wR2	=	0.1009	299	
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(wR2	all	data	=	0.1048),	gof	=	1.064.	CCDC	983369	contains	the	300	 supplementary	crystallographic	data	for	this	paper.	These	data	can	be	301	 obtained,	free	of	charge,	via	302	 http://www.ccdc.cam.ac.uk/products/csd/request/	(or	from	the	Cambridge	303	 Crystallographic	Data	Centre,	12	Union	Road,	Cambridge	CB2	1EZ,	U.K.	(Fax:	304	 44-1223-336033	or	e-mail:	deposit@ccdc.cam.ac.uk)).		305	 	306	
	307	 Scheme	1.		Structures	of	ligands	1–4	and	of	Phtpy	and	pytpy,	with	atom	308	 numbering	used	for	NMR	spectroscopic	assignments;	when	R	=	H,	ring	A	=	309	 ring	D.	310	 	311	
Results	and	discussion	312	
Synthesis	and	characterization	of	ligands	1	and	2		313	 Compounds	1	and	2	(Scheme	1)	are	the	4'-phenyl	and	4'-(4-pyridyl)	314	 analogues	of	4'-tolyl-2,2':6',2''-terpyridine,	the	preparation	and	homoleptic	315	 ruthenium(II)	complex	of	which	were	reported	a	decade	ago	by	Potvin	and	316	
N
N
N N N
N
N
N
N
P
N
RO OR'
O
pytpy  R = H
2         R = CO2Me
3  R = R' = Et
4  R =H;  R' = Et
E
A
B
A
B
F
C C
D D
3
3
3
3
3
3
3 3 3
3
2
4
4 4
4
2
5 5
5
6
6 6
5 5
6 6
RR
Phtpy  R = H
1         R = CO2Me
5 5
	 14	
coworker.25	Scheme	2	shows	the	Kröhnke	synthesis	of	1	and	2	which	317	 yielded	the	compounds	in	33	and	89%,	respectively,	as	white	solids.	In	the	318	 electrospray	mass	spectrum		of	1,	the	base	peak	(m/z	=	338.0)	arises	from	319	 the	[M+H]+	ion,	and	a	lower	intensity	peak	at	m/z	=	390.0	was	assigned	to	320	 [M+Na]+.	Corresponding	peaks	at	m/z	369.2	and	391.1	in	the	mass	spectrum	321	 of	2	were	also	observed.	The	1H	and	13C	NMR	spectra	of	1	and	2	were	fully	322	 assigned	with	COSY,	HMQC	and	HMBC	techniques	and	were	consistent	with	323	 the	inequivalence	of	the	outer	pyridine	rings	of	the	tpy	domain	(Scheme	1)	324	 and	the	presence	of	the	ester	group.				325	 			326	
	327	 	328	 Scheme	2.		Synthetic	route	to	ligands	1	and	2.	Conditions:	(i)	MeOH,	reflux.	329	 	330	 Single	crystals	of	1	were	grown	by	slow	evaporation	from	a	CHCl3	solution	of	331	 the	compound	and	the	structure	(Figure	1)	was	confirmed	by	X-ray	332	 diffraction.	Important	bond	parameters	are	given	in	the	figure	caption.	The	333	 tpy	unit	adopts	a	trans,trans-conformation,	which	is	expected	for	a	non-334	 protonated	ligand.	The	tpy	domain	is	essentially	planar	(the	angles	between	335	 the	least	squares	planes	through	the	rings	containing	N1/N2	and	N2/N3	=	336	 5.5	and	4.5o);	the	phenyl	ring	is	twisted	27.6o	with	respect	to	the	pyridine	337	 ring	to	which	it	is	attached,	consistent	with	minimizing	H...H	repulsions	338	 between	the	two	rings.	The	dominant	packing	interactions	are	(i)	face-to-339	
N
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I
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face	π-stacking	of	tpy	domains	across	inversion	centres,	(ii)	Hmethyl...Npyridine	340	 contacts	(H23A...N1i	=	2.98,	H23B...N1i	=	2.81	Å,	symmetry	code	i	=	1+x,	1+y,	341	
z),	and	(iii)	Npyridine...HC	contacts	(N3...H3Aii–C3ii	=		2.57	Å,	symmetry	code	ii	342	 =	x,	3/2	–	y,	1/2	+	z).	343	 	344	
	345	 Fig.	1.		ORTEP	representation	of	the	structure	of	1	(ellipsoids	plotted	at	50%	346	 probability	level).	Selected	bond	parameters:	N1–C1	=	1.342(2),	N1–C5	=	347	 1.3386(19),	N2–C6	=	1.3415(18),	N2–C10	=	1.3412(17),	N3–C11	=	348	 1.3463(17),	N3–C15	=	1.3295(19),	C13–C22	=	1.4993(19),	O1–C22	=	349	 1.2052(18),	C22–O2	=	1.3309(18),	O2–C23	=	1.4524(18)	Å;	C5–N1–C1	=	350	 117.26(13),	C6–N2–C10	=	117.72(12),	C15–N3–C11	=	117.80(12),	O1–C22–351	
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O2	=	124.63(13),	O1–C22–C13	=	124.21(13),	O2–C22–C13	=	111.15(12),	352	 C22–O2–C23	=	117.15(12)o.	353	 	354	 	355	 	 The	diethylphosphonate-functionalized	ligand	3	has	previously	been	356	 reported	by	Grätzel	and	coworkers.20	The	literature	synthesis	(which	gives	357	
3	in	72.3%	yield)	involves	the	[Pd(PPh3)4]	catalysed	reaction	of	4'-bromo-358	 2,2':6',2''-terpyridine	with	diethyl	phosphite	in	NEt3	(95	oC	for	3	h)	followed	359	 by	dissolution	of	the	mixture	in	MeOH	and	chromatographic	workup.	We	360	 adopted	the	more	convenient	strategy	shown	in	Scheme	2.	The	4'-triflate-361	 functionalized	tpy	was	readily	prepared	according	to	the	route	described	by	362	 Potts	et	al,19	and	diethylphosphonate	for	triflate	substitution	occurs	under	363	 microwave	conditions	to	give	4	in	84%	yield.	The	NMR	spectroscopic	data	364	 for	4	were	consistent	with	those	published.20	365	 	366	
	367	 Scheme	3.	Synthesis	of	phosphonate	4.	Conditions:	(i)	[Pd(PPh3)4],	NEt3,	368	 HP(O)(OEt)2,	MeCN,	140	oC,	30	min.	369	 	370	
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The	heteroleptic	complexes	discussed	in	this	section	are	summarized	in	373	 Scheme	4.	Heteroleptic	[Ru(Xtpy)(Ytpy)]2+	complexes	are	typically	prepared	374	 by	first	preparing	an	insoluble,	paramagnetic	ruthenium(III)	complex	375	 [Ru(Xtpy)Cl3],	and	treating	this	crude	material	with	Ytpy	in	the	presence	of	376	
N-ethylmorpholine	which	acts	as	a	reducing	agent.26		The	precursor	for	the	377	 formation	of	the	new	ruthenium(II)	complexes	was	[Ru(3)Cl3],	prepared	by	378	 reaction	of	RuCl3.3H2O	with	compound	3	in	MeOH	under	reflux.	[Ru(3)Cl3]	379	 was	isolated	as	a	brown	solid.		 	380	
	381	 Scheme	4.	Structures	of	the	heteroleptic	complex	cations	prepared	as	382	 hexafluoridophosphate	salts.	383	 	 	384	 Model	compounds	containing	Phtpy	and	pytpy	(Scheme	1)	were	first	385	 prepared	by	reaction	of	[Ru(3)Cl3]	with	Phtpy	and	pytpy	in	the	presence	of	386	
N-ethylmorpholine.	After	anion	exchange	and	chromatographic	workup,	387	 followed	by	a	second	anion	exchange	(to	remove	[NO3]–	introduced	from	388	 aqueous	KNO3	in	the	eluant),	the	ruthenium(II)	salts	were	isolated	as	red	389	 solids.	Electrospray	mass	spectrometic	and	NMR	spectroscopic	data	were	390	
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consistent	with	the	isolated	products	being	complexes	of	the	monoester	4	391	 (Scheme	2)	rather	than	the	diester	3.	Partial	hydrolysis	of	3	during	392	 synthesis	of	ruthenium(II)	complexes	is	known	to	occur	under	conditions	of	393	 high	temperature	reflux20	or	heating	in	DMF	at	60	oC.27	The	second	394	 hydrolysis	step	to	the	phosphonic	acid	needs	acidic	conditions	or	treatment	395	 with	Me3SiBr.	The	ESI	mass	spectrum	of	[Ru(Phtpy)(4)][PF6]2	showed	the	396	 base-peak	envelope	at	m/z	751.4	with	an	appropriate	isotope	pattern	for	397	 the	ion	[M	–	H	–	2PF6]+.	The	loss	of	H+	is	consistent	with	the	presence	of	the	398	 acidic	P–OH	group.	The	high	resolution	ESI	(HR-ESI	)	mass	spectrum	was	399	 also	recorded	and	peaks	arising	from	[M	–	H	–	2PF6]+	and	[M	–	2PF6]2+	400	 confirmed	the	identity	of	[Ru(Phtpy)(4)]2+	.	The	HR-ESI	mass	spectrum	of	401	 [Ru(pytpy)(4)][PF6]2	exhibited	peak	envelopes	arising	from	the	[M	–	H	–	402	 2PF6]+	and	[M	–	2PF6]2+	ions,	and	the	latter	was	also	observed	in	the	ESI	403	 mass	spectrum.				404	 	 The	1H	and	13C	NMR	spectra	of	CD3CN	solutions	of	405	 [Ru(Phtpy)(4)][PF6]2	and	[Ru(pytpy)(4)][PF6]2	were	consistent	with	the	406	 presence	of	two	tpy	environments	in	each	complex.	A	representative	407	 spectrum	is	shown	in	Figure	2.	Spectra	were	assigned	using	2D	methods	408	 (COSY,	HMQC	and	HMBC);	400	MHz	1H	spectra	were	routinely	recorded	for	409	 better	resolution	of	signals	and	500	MHz	1H	for	2D	measurements.	The	most	410	 characteristic	feature	of	the	spectrum	in	Figure	2	is	the	appearance	of	a	411	 singlet	for	protons	HB3	(Phtpy	ligand)	and	a	doublet	for	the	corresponding	412	 protons	HF3	(ligand	4)	arising	from	31P-1H	coupling	(11	Hz).	For	413	 [Ru(Phtpy)(4)][PF6]2,	signals	at	∂	4.05	and	1.31	ppm	in	the	1H	NMR	414	 spectrum	and	their	relative	integrals	with	respect	to	resonances	in	the	415	
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aromatic	region	were	consistent	with	the	monoester	4;	in	the	13C	NMR	416	 spectrum,	corresponding	signals	at	∂	61.8	and	17.5	ppm	were	observed.		417	
	418	 Fig.	2	Aromatic	region	of	the	400	HMz	1	H	NMR	spectrum	of	419	 [Ru(Phtpy)(4)][PF6]2.	See	Scheme	1	for	ring	labelling.	420	 	421	 	 The	preparations	of	[Ru(1)(4)][PF6]2	and	[Ru(2)(4)][PF6]2	were	422	 carried	out	in	an	analogous	manner	to	those	of		[Ru(Phtpy)(4)][PF6]2	and	423	 [Ru(pytpy)(4)][PF6]2.	The	base	peak	in	the	ESI	mass	spectrum	of	424	 [Ru(1)(4)][PF6]2	was	assigned	to	[M	–	H	–	2PF6]+;	for	[Ru(2)(4)][PF6]2,	the	425	 main	peak	envelope	arose	from	[M	–	2PF6]2+.	High	resolution	ESI	data	426	 showed	peaks	arising	from	[M	–	2PF6]2+	and	[M	–	H	–	2PF6]+	for	both	427	 complexes.	The	solution	1H	and	13C	NMR	spectra	(assigned	by	2D	methods)	428	 of	[Ru(1)(4)][PF6]2	and	[Ru(2)(4)][PF6]2	were	consistent	with	the	presence	429	 of	the	symmetrical	ligand	4	and	one	asymmetrical	ligand.	Figure	3	shows	430	 part	of	the	1H	NMR	spectrum	of	[Ru(2)(4)][PF6]2.	The	doublet	for	HF3	(JPH	=	431	 11.5	Hz)	overlaps	with	one	of	the	two	doublets	(JHH	1.3	or	1.5	Hz)	arising	432	
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from	HB3	and	HB5.	Pairs	of	signals	for	HE3/HA3,	HE4/HA4,	HE5/HA5	and	HE6/HA6	433	 with	relative	integrals	2	:	1	appear	for	the	unsubstituted	pyridine	rings	in	434	 ligand	4	and	for	ligands	1	or	2,	respectively	The	signal	for	HD3	(JHH=	1.4	Hz)	435	 was	distinguished	from	those	of	HB3	and	HB5	by	its	COSY	signature.	The	436	 relative	integrals	for	the	signals	for	the	ethyl	groups	in	4	in	both	complexes	437	 were	consistent	with	the	monoester.	438	 	439	
	440	 Fig.	3	Aromatic	region	of	the	500	HMz	1	H	NMR	spectrum	of	441	 [Ru(2)(4)][PF6]2.	See	Scheme	1	for	ring	labelling.	442	 	443	 	 Yields	of	[Ru(Phtpy)(4)][PF6]2	and	[Ru(1)(4)][PF6]2	were	>80%	444	 yield,	but	for	the	complexes	containing	pytpy,	lower	yields	of	ca.	25%	were	445	 observed,	due,	in	part,	to	formation	of	some	of	the	N-protonated	species.	We	446	 noted	changes	in	the	1H	NMR	spectra	which	were	consistent	with	447	 protonation	of	samples	in	solution.	Satisfactory	elemental	analysis	could	not	448	 always	be	obtained	for	the	hexafluoridophosphate	salts,	probably	due	to	449	 small	amounts	of	residual	NH4PF6.	Traces	of	[NH4]+	were	seen	in	the	1H	NMR	450	 spectra	(∂	6.02,	J(14N1H)		=	53	Hz)	of	some	batches	of	the	complexes.	X-ray	451	
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quality	crystals	of	solvated	[Ru(pytpy)(4)][PF6]2	were	obtained,	but	only	452	 preliminary	structural	data	could	be	obtained	because	of	persistent	453	 twinning	problems.	However,	these	data	were	sufficient	to	confirm	the	454	 presence	of	the	monoester	ligand	4	and	the	octahedral	coordination	455	 environment	of	the	ruthenium(II)	centre	bound	by	the	bis(chelating)	donor	456	 sets	of	pytpy	and	ligand	4.	Despite	attempts,	X-ray	quality	single	crystals	of	457	 the	other	ruthenium(II)	complexes	were	not	obtained.		458	 	459	
Absorption	and	emission	spectroscopic	properties	460	 The	absorption	spectra	of	MeCN	solutions	of	the	complexes	are	shown	in	461	 Figure	4.	Each	exhibits	a	series	of	high-energy	bands	arising	from	ligand-462	 based,	spin-allowed	transitions,	and	a	broad	MLCT	band	in	the	visible	463	 region.	The	values	of	λmax	for	the	MLCT	absorptions	(485–491	nm,	see	464	 experimental	section)	compare	with	488	nm	for	both	[Ru(Phtpy)2][PF6]226	465	 and	[Ru(pytpy)2][PF6]2.28	The	spectra	for	[Ru(Phtpy)(4)][PF6]2	and	466	 [Ru(pytpy)(4)][PF6]2	are	similar	to	one	another	and	to	those	of	the	467	 homoleptic	complexes	[Ru(Phtpy)2][PF6]226	and		[Ru(pytpy)2][PF6]2.28	The	468	 introduction	of	the	methyl	ester	substituent	leads	to	a	change	in	the	469	 appearance	of	the	absorption	maxima	(Figure	4),	the	trend	being	the	same	470	 on	going	from	[Ru(Phtpy)(4)][PF6]2	to	[Ru(1)(4)][PF6]2,	and	from	471	 [Ru(pytpy)(4)][PF6]2	to	[Ru(2)(4)][PF6]2.	The	small	red-shift	in	the	MLCT	472	 band	upon	introduction	of	the	CO2Me	group	is	consistent	with	that	observed	473	 on	going	from	[Ru(ttpy)2]2+	to	[Ru(4-MeO2Cttpy)2]2+	(ttpy	=	4'-tolyl-474	 2,2':6',2''-terpyridine;	4-MeO2Cttpy	=	4-carboxymethyl-4'-tolyl-2,2':6',2''-475	 terpyridine).25	476	
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	477	
	478	 Fig.	4.	Absorption	spectra	of	MeCN	solutions	of	[Ru(Phtpy)(4)][PF6]2,	479	 [Ru(pytpy)(4)][PF6]2,	[Ru(1)(4)][PF6]2	and	[Ru(2)(4)][PF6]2.	See	480	 experimental	section	for	concentrations.	481	 	482	 	 Excitation	into	the	MLCT	band	of	each	of	[Ru(Phtpy)(4)][PF6]2	and	483	 [Ru(1)(4)][PF6]2	(in	degassed	MeCN	at	room	temperature)	gives	rise	to	a	484	 weak	emission	at	647	and	665	nm,	respectively,	with	a	quantum	yield	below	485	 the	detection	limit	of	the	instrument	(QY	<1%).	486	 	487	
Electrochemical	properties	488	 The	complexes	are	electrochemically	active	and	cyclic	voltammetric	data	are	489	 given	in	Table	1.	The	reversible	oxidation	observed	for	each	complex	arises	490	 from	the	Ru2+/Ru3+	couple.	For	the	parent	[Ru(tpy)2]2+,	this	process	occurs	491	 at	+0.918	V,26	and	introducing	electron-donating	phenyl	groups	shifts	it	to	492	 lower	potential	(+0.895	V	in	[Ru(Phtpy)2][PF6]2).26	Replacing	one	phenyl	493	 substituent	by	the	electron-withdrawing	phosphonic	ester	group	shifts	the	494	
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oxidation	to	+0.93	V	(Table	1).	A	similar	trend	is	seen	on	comparing	the	495	 Ru2+/Ru3+	potential	in	[Ru(pytpy)2][PF6]2	(+0.95	V)28	with	that	in	496	 [Ru(pytpy)(4)][PF6]2	(+1.01	V).	Introduction	of	the	methyl	ester	unit	results	497	 in	a	0.03	V	shift	to	more	positive	potential	on	going	from	498	 [Ru(Phtpy)(4)][PF6]2	to	[Ru(1)(4)][PF6]2,	or	from	[Ru(pytpy)(4)][PF6]2	to	499	 [Ru(2)(4)][PF6]2.	This	is	consistent	with	the	trend	observed	from	500	 [Ru(ttpy)2]2+	to	[Ru(4-MeO2Cttpy)2]2+.25	A	series	of	ligand-based	reduction	501	 processes	is	observed	for	each	complex	(Table	1),	consistent	with	502	 expectations	based	on	related	compounds.		503	 	504	 	505	 Table	1.	Cyclic	voltammetric	data	for	the	ruthenium(II)	complexes	with	506	 respect	to	Fc/Fc+	in	MeCN	solutions	with	[tBu4N][PF6]	as	supporting	507	 electrolyte,	and	a		scan	rate	of	0.1	V	s–1	(ir	=	irreversible;	qr	=	quasi-508	 reversible).		 	509	 Complex	 	E1/2ox	/	V	 	E1/2red	/	V	[Ru(Phtpy)(4)][PF6]2	 +0.93	 –1.68,	–1.93qr	[Ru(1)(4)][PF6]2	 +0.96	 –1.49,	–1.90,	–2.23ir	[Ru(pytpy)(4)][PF6]2	 +1.01	 –1.57,	–2.00ir	[Ru(2)(4)][PF6]2	 +1.04	 –1.43,	–1.85			510	 	511	
Conclusions	512	 We	have	prepared	and	characterized	four	new	heteroleptic	complexes	513	 containing	{Ru(tpy)2}-cores.	One	ligand	contains	a	phosphonate	ester	group	514	
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designed	to	act	as	an	anchoring	group	to	metal	oxide	surfaces.	The	second	515	 ligand	is	Phtpy	or	pytpy	in	the	model	systems	and	contains	a	methyl	ester	516	 functionality	in	the	second	of	each	pair	of	complexes.	This	provides	a	517	 suitable	site	for	variable	functionalization,	for	example,	through	518	 transesterification.	We	plan	to	use	the	heteroleptic	complexes	as	a	starting	519	 point	for	development	of	ruthenium(II)	dyes	suited	for	sensitization	of	p-520	 type	semiconductors.		521	
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